Literature DB >> 30956968

Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib.

Jun Ho Yi1, Hye Ryoun Kim2.   

Abstract

Entities:  

Year:  2019        PMID： 30956968      PMCID： PMC6439304          DOI： 10.5045/br.2019.54.1.77

Source DB:  PubMed          Journal:  Blood Res        ISSN： 2287-979X


× No keyword cloud information.
  1 in total

1.  Clinical significance of myeloproliferative neoplasms with JAK2V617F mutations and major BCR-ABL1 translocations: a literature review with case presentation.

Authors:  Bohyun Kim; Kyu Taek Lee; Young Ahn Yoon; Young-Jin Choi
Journal:  Blood Res       Date:  2020-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.